OSYPKA MEDICAL

What OSYPKA MEDICAL does

OSYPKA MEDICAL GmbH is a Berlin-headquartered, privately held German medical technology company founded in 1986 by Dr. Peter Osypka. The company develops, manufactures, and sells specialty cardiovascular devices in two technology platforms: (1) Electrical Cardiometry™ (EC™), a patented non-invasive hemodynamic monitoring method using thoracic electrical bioimpedance to continuously derive cardiac output, stroke volume, contractility, fluid status, vascular resistance, and oxygenation parameters from four adhesive skin sensors (commercialized via the ICON® handheld and ICONCore® portable cardiometers, iSense® sensors, and iControl™ software); and (2) Temporary Cardiac Pacing, external pacemaker systems including PACE® Models 101, 203, and 300 (single-, dual-, and triple-chamber), with disposable MyoStim® electrodes, EndoStim® leads, and StimConnect® cables. The company is currently legally represented by Dr. Markus Osypka and employs approximately 40 people across Berlin and San Diego.

The business model is hardware sales of niche specialty medical devices, sold direct from Berlin (for Europe, Middle East, Asia, Australia, New Zealand) and San Diego (for the Americas), and through a global network of 40+ authorized distributors complemented by wholly-owned regional subsidiaries (OM ASIA Ltd. in Hong Kong, Osypka Medical Asia Co., Ltd. in Taiwan, OSYPKA AG in Germany). Supporting offerings include the CoraSim® interactive heart simulator for training and the OSYPKA MEDUCATE® continuing medical education platform. Pricing is quote-based rather than publicly disclosed.

The company sells primarily into hospitals and medical centers (ICUs, ORs, NICUs) for non-invasive hemodynamic monitoring and into cardiac care and electrophysiology departments for temporary pacing. Its primary differentiated value proposition is a non-invasive, continuous alternative to invasive Swan-Ganz catheter-based monitoring that is safe for neonates, pediatric, and other patient populations where invasive methods are inadvisable, supported by over 100 published clinical studies validating the methodology against gold-standard thermodilution and broad U.S. FDA market-released labeling across all age groups.

Name

OSYPKA MEDICAL

Legal name

OSYPKA MEDICAL GmbH

Website

https://osypkamed.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

11–50 employees

Short description

OSYPKA MEDICAL GmbH is a Berlin-based, privately held medical device company that manufactures patented non-invasive Electrical Cardiometry™ hemodynamic monitors (ICON®, ICONCore®) and temporary external cardiac pacemakers (PACE®), serving hospitals, ICUs/ORs/NICUs, and cardiology departments globally through 40+ distributors.

Ownership category

akta.pro rank

Product category

Cardiac Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

akta.pro secondary industries

Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB), Electrophysiology (Heart Rhythm) (HLAKABAC)

Keywords

• Non-invasive hemodynamic monitoring
• External cardiac pacemakers
• Electrical cardiometry devices
• Temporary pacing electrodes
• Cardiac medical devices

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of hemodynamic monitoring devices (ICON®, ICONCore®), temporary cardiac pacemakers (PACE® models), sensors (iSense®), disposables (MyoStim®, EndoStim®, StimConnect®), and heart simulators (CoraSim®). Revenue generated from direct sales and through global distributor network.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

OSYPKA MEDICAL develops and manufactures specialized medical devices for cardiovascular diagnosis and therapy, divided into two core product lines. The first line consists of non-invasive hemodynamic monitoring devices based on the proprietary Electrical Cardiometry™ (EC™) method (ICON®, ICONCore®, iSense® sensors with iControl™ software). The second line consists of external temporary cardiac pacemakers (PACE® models 101, 203, 300) along with disposable pacing accessories (MyoStim®, EndoStim®, StimConnect®), used in cardiac surgery and electrophysiology procedures.

Product overview

OSYPKA MEDICAL develops, manufactures, and sells medical devices focused on cardiovascular diagnosis and therapy. The company operates two main technology platforms: Electrical Cardiometry™ (EC™) for non-invasive hemodynamic monitoring, and Temporary Cardiac Pacing for external pacemaker therapy. The EC™ portfolio centers on the ICON® handheld cardiometer and ICONCore® portable cardiometer, used with iSense® sensors and iControl™ PC software. The Temporary Cardiac Pacing portfolio includes the PACE® Model 101 (unicameral), PACE® Model 203 (bicameral), and PACE® Model 300 (three-chamber) external pacemakers, along with disposable accessories (MyoStim® electrodes, EndoStim® leads, StimConnect® cables). Supporting products include the CoraSim® interactive heart simulator for training and the OSYPKA MEDUCATE® education platform. The company was founded in 1986 by Dr. Peter Osypka, is headquartered in Berlin, Germany, and employs approximately 40 people across Berlin and San Diego, California.

Differentiator

Problem solved

Functional benefit

Brands

• ICON: Hand-held non-invasive cardiometer for Electrical Cardiometry hemodynamic monitoring
• ICONCore
• iSense
• Electrical Cardiometry (EC)
• PACE
• CoraSim
• OSYPKA MEDUCATE
• MyoStim
• EndoStim
• StimConnect

Products and services

• ICON® Hand-held, lightweight, and portable non-invasive cardiometer for clinical use, measuring stroke volume, cardiac output, and hemodynamic parameters using Electrical Cardiometry™ (EC™) technology; intended for use by clinicians across emergency, peri-operative, and critical care settings.
• ICONCore® Portable non-invasive cardiometer paired with the iControl™ PC software application for continuous hemodynamic monitoring via Electrical Cardiometry™; used by clinicians to track patient status with Compass™ diagnostic visualization, including trending of cardiac output and thoracic fluid content.
• iSense® Sensors Adhesive skin sensors used with ICON® and ICONCore® devices to capture thoracic electrical bioimpedance signals for Electrical Cardiometry™ measurements; available in adult, pediatric, and neonatal sizes to support all patient populations.
• iControl™ PC-based software application that runs on the ICONCore® platform to display, trend, and analyze hemodynamic data captured by Electrical Cardiometry™; provides Compass™ diagnostic visualization for clinicians in peri-operative and critical care environments.
• PACE® Model 101 Single-chamber external temporary cardiac pacemaker designed for use following cardiac surgery or for emergency pacing; supports asynchronous and demand modes for adult, pediatric, and neonatal patients.
• PACE® Model 203 Dual-chamber external temporary cardiac pacemaker providing physiological A-V sequential pacing for cardiac surgery patients; supports advanced pacing modes and is suited to cardiac surgery, electrophysiology, and pediatric cardiology departments.
• PACE® Model 300 Triple-chamber external temporary cardiac pacemaker designed for bi-ventricular (CRT) pacing and complex electrophysiology procedures following cardiac surgery; enables pacing of the right atrium, right ventricle, and left ventricle simultaneously.
• MyoStim® Disposable temporary myocardial pacing electrodes placed directly onto the heart's epicardium during cardiac surgery for postoperative temporary pacing; intended for use by cardiac surgeons and operating-room personnel.
• EndoStim® Disposable temporary pacing leads designed for transvenous insertion to enable temporary cardiac pacing for diagnostics, emergency intervention, and bridge to permanent pacemaker implantation.
• StimConnect® Cables, adapters, and connectors used to interface pacing electrodes and leads with external pacemaker devices (PACE® series); provides a complete accessory ecosystem for temporary pacing procedures.
• CoraSim® Heart simulator device used to validate pacemaker functionality, conduct training, and support product development; used in clinical engineering, field service, and medical training contexts.
• OSYPKA MEDUCATE® Medical education and training platform offering instruction on pacemaker operation, hemodynamic monitoring with Electrical Cardiometry™, and clinical application of OSYPKA devices; targeted at clinicians, biomedical engineers, and trainees.

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Ten partnerships are on record, tiered core.

• CardiotroniccoreChannel Partner/ Reseller/ DistributorAuthorized distributor for United States and the Americas, headquartered in La Jolla, CA 92037. Provides sales, support, and customer service for Osypka Medical products in the Americas region.
• OSYPKA AGcoreChannel Partner/ Reseller/ DistributorAuthorized distributor for Germany, headquartered in Rheinfelden, Germany. Part of the Osypka Group of companies.
• International Care GroupcoreChannel Partner/ Reseller/ DistributorRegional office for Middle East and Africa (MEA), located in RAK Free Trade Zone, UAE. Handles distribution across the MEA region including UAE, Kuwait, Qatar, Turkey, Lebanon, Jordan, Syria, Palestine, Egypt, and South Africa.
• OM Asia Ltd.coreChannel Partner/ Reseller/ DistributorAsia Pacific Regional Office handling distribution in Australia, Hong Kong, Malaysia, Philippines, Singapore, and Vietnam. Located in Wanchai, Hong Kong.
• DOT Medical LtdcoreChannel Partner/ Reseller/ DistributorAuthorized distributor for Great Britain and Ireland, providing sales and support for Osypka Medical products in the UK market.
• Heiwa Bussan Co., Ltd.coreChannel Partner/ Reseller/ DistributorAuthorized distributor for Japan, headquartered in Chiyoda-ku Tokyo. Handles sales and distribution of Osypka Medical products in the Japanese market.
• DiMedCarecoreChannel Partner/ Reseller/ DistributorAuthorized distributor for France, located in Saint-Médard-en-Jalles. Provides sales and support for Osypka Medical products in the French market.
• Biogen Diagnostica S.L.coreChannel Partner/ Reseller/ DistributorAuthorized distributor for Spain and Portugal, located in Villaviciosa de Odón, Madrid. Handles sales and distribution of Osypka Medical products in the Iberian Peninsula.
• Webbit S.r.lcoreChannel Partner/ Reseller/ DistributorAuthorized distributor for Italy, located in Trezzano sul Naviglio (Milan). Provides sales and support for Osypka Medical products in the Italian market.
• Medu Sverige ABcoreChannel Partner/ Reseller/ DistributorAuthorized distributor for Sweden, Norway, and Denmark, headquartered in Sollentuna, Sweden. Handles sales and distribution across the Nordic region.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Biotronik: Biotronik manufactures implantable pacemakers, ICDs, and cardiac monitoring devices and competes in the broader cardiac rhythm and pacing space where Osypka's temporary pacemaker systems are sold.
• Nihon Kohden: Nihon Kohden is a major Japanese manufacturer of patient monitors, ECG systems, and cardiac diagnostic equipment, serving many of the same hospital ICU, OR, and cardiology departments that Osypka targets globally.
• Edwards Lifesciences: Edwards Lifesciences is the dominant player in invasive hemodynamic monitoring with the Swan-Ganz catheter and FloTrac/Vigileo systems. While invasive-leaning, it competes with Osypka in the broader hemodynamic monitoring market across ICUs and ORs.
• Philips (Patient Monitoring): Philips' IntelliVue and similar patient monitoring platforms dominate hospital ICU and OR monitoring. They compete with Osypka's EC™ devices as integrated suites that can either incorporate or substitute for standalone hemodynamic monitors.
• GE HealthCare: GE HealthCare's CARESCAPE and Dash patient monitoring systems are widely deployed in ICUs and ORs, representing the integrated incumbent alternative to Osypka's standalone non-invasive hemodynamic monitors.
• Medtronic: Medtronic is the global pacemaker market leader. While primarily focused on implantable devices, it competes with Osypka's PACE® temporary pacemaker line in hospitals and electrophysiology labs for procedural and post-operative temporary pacing.
• Masimo: Masimo's Rainbow SET platform provides non-invasive monitoring of multiple parameters including SpHb and PVi. Masimo is referenced in Osypka's own documentation as a third-party brand integrated with Osypka devices, making it both a technology partner and broader patient monitoring competitor.

Direct peers

• CNSystems: CNSystems (now part of BD) manufactures non-invasive continuous hemodynamic monitoring products (CNAP, Task Force Monitor) that directly compete with Osypka's ICON®/ICONCore® devices across OR, ICU, and autonomic function testing.
• Deltex Medical: Deltex Medical develops the CardioQ oesophageal Doppler, a non-invasive (minimally invasive) hemodynamic monitoring system used in surgical and critical care settings. It competes directly with Osypka's EC™ platform for clinicians seeking alternatives to invasive pulmonary artery catheters.

Emerging players

• Schiller: Schiller specializes in cardiopulmonary diagnostics including ECG, defibrillation, and patient monitoring. It is a comparable European mid-sized specialty cardiac device company with overlapping customer segments in hospitals and clinics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/osypka-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OSYPKA MEDICAL